🇺🇸 FDA
Patent

US 10071957

N-substituted benzamides and methods of use thereof

granted A61KA61K31/44A61K31/4439

Quick answer

US patent 10071957 (N-substituted benzamides and methods of use thereof) held by Xenon Pharmaceuticals Inc. expires Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Xenon Pharmaceuticals Inc.
Grant date
Tue Sep 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K31/44, A61K31/4439, A61K31/444, A61P